References

Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials

10.1634/theoncologist.2008-0083 · 2008 · External reference

Estimates of the cancer incidence and mortality in Europe in 2006

10.1093/annonc/mdl498 · 2007 · External reference

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer

10.1056/nejmoa032709 · 2004 · External reference

Platinum neurotoxicity pharmacogenetics

10.1158/1535-7163.mct-08-0840 · 2009 · External reference

Mangafodipir (MnDPDP) and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries

10.1016/s0022-3565(25)23807-1 · 1994 · External reference

Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium

10.1080/028418501127347340 · 2001 · External reference

Contrast-enhanced MR imaging in the diagnosis and preservation of cardiac viability [editorial]

2001 · External reference

Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity [editorial]

10.1093/jnci/djj065 · 2006 · External reference

Mangafodipir prevents liver injury induced by acetaminophen in the mouse

10.1016/s0168-8278(03)00325-8 · 2003 · External reference

Antioxidant activity of mangafodipir is not a new finding [letter to the editor]

10.1016/j.jhep.2004.02.022 · 2004 · External reference

Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir

10.1093/jnci/djj049 · 2006 · External reference

The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity [letter to the editor]

10.1158/0008-5472.can-05-2053 · 2006 · External reference

Controlling tumor growth by modulating endogenous production of reactive oxygen species

10.1158/0008-5472.948.65.3 · 2005 · External reference

Mangafodipir as a cytoprotective adjunct to chemotherapy—a case report

10.1080/02841860802680427 · 2009 · External reference

Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties

10.1006/bbrc.1998.0131 · 1999 · External reference

Manganese(II) N,N ′-dipyridoxylethylenediamine-N,N′-diacetate 5,5′-bis (phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement

10.1021/ic00302a019 · 1989 · External reference

Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts

10.1073/pnas.93.21.11853 · 1996 · External reference

Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase

10.1124/jpet.110.176321 · 2010 · External reference

Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancer: a single center experience

10.1385/mo:23:3:347 · 2006 · External reference

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer

10.1200/jco.2002.20.6.1491 · 2002 · External reference

Therapeutic use and profile of toxicity of the FOLFOX4 regimen

10.1016/s1130-6343(09)70993-6 · 2009 · External reference

Chemotherapy dose intensity and quality cancer care

2006 · External reference

Impact of chemotherapy dose intensity on cancer patient outcomes

10.6004/jnccn.2009.0009 · 2009 · External reference